Arcturus Therapeutics Holdings (ARCT) Total Debt (2018 - 2025)

Arcturus Therapeutics Holdings' Total Debt history runs 7 years deep, the most recent figure standing at $15.0 million for Q1 2025.

• Quarterly Total Debt changed N/A year-over-year to $15.0 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $15.0 million (changed N/A YoY) and the FY2022 annual result came in at $111.1 million, up 75.98% from the prior year.
• Total Debt was $15.0 million for Q1 2025 at Arcturus Therapeutics Holdings, down from $20.0 million in the prior quarter.
• Across five years, Total Debt topped out at $111.1 million in Q4 2022 and bottomed at $15.0 million in Q1 2025.
• A 4-year average of $57.9 million and a median of $61.3 million in 2021 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2021 — Total Debt soared 318.07% — and 2023, when it plunged 66.52%.
• Arcturus Therapeutics Holdings' Total Debt stood at $63.1 million in 2021, then jumped by 75.98% to $111.1 million in 2022, then slumped by 81.99% to $20.0 million in 2023, then slipped by 25.0% to $15.0 million in 2025.
• Business Quant data shows ARCT's Total Debt at $15.0 million in Q1 2025, $20.0 million in Q3 2023, and $111.1 million in Q4 2022.